Med-Rx IV Kits Recalled Over Discoloration in Drip Chamber: Health Canada

Health Canada has published a Type II medical device recall notice covering select lots of the Med-Rx Medication/Primary Solution Administration Kit after discoloration was found in the drip chamber of the IV sets used in the kit. The notice, issued through Canadian Hospital Specialties Ltd., doing business as CHS, was published on August 26, 2026, with the underlying recall dated August 11, 2026.

According to the notice, CHS was alerted by ICU Medical Canada that it is conducting its own recall of certain IV sets after discoloration was observed inside the drip chamber component. CHS incorporates these ICU Medical IV tubing sets into the medical devices it manufactures and distributes, which is why the issue extends to the Med-Rx Medication/Primary Solution Administration Kit sold under the CHS brand.

Which Items Are Involved?

The recall applies specifically to Med-Rx Medication/Primary Solution Administration Kits that fall within their expiration date and carry a drip chamber. Health Canada’s listing identifies ten affected lot numbers tied to three catalogue or model numbers:

• Model CS005037 — lots 207742, 210781, and 213769
• Model CS005042 — lots 203639, 207747, 209995, and 209997
• Model CS005021 — lots 203317, 203446, and 203705

The product category is listed as health products, medical devices, for general hospital and personal use, with an industry-only audience designation.

What Went Wrong?

The root issue traces back to ICU Medical Canada, which found that discoloration can appear in the drip chamber of certain IV sets still within their labeled expiration date. Because CHS builds these IV sets into its own administration kits, the discoloration issue was passed along to the finished Med-Rx product. Health Canada has classified the action as a Type II recall, a category generally reserved for situations where a defect could cause temporary or medically reversible health effects, or where the probability of a serious health impact is considered low.

Notably, the notice does not direct facilities to pull the kits from use immediately. Instead, it states that the products should continue to be used as intended and per facility protocol, suggesting the discoloration is being treated as a quality and monitoring concern for industry users rather than an immediate stop-use hazard.

Who Should Be Concerned

This recall is directed at an industry audience rather than individual consumers. Hospitals, clinics, and other healthcare facilities in Canada that received the affected Med-Rx Medication/Primary Solution Administration Kits from CHS are the intended recipients of this notice. CHS operates from two Oakville, Ontario locations — 2760 Brighton Road and 2060 Winston Park Drive — and both are listed as companies associated with the recall.

Because the notice does not specify a national distribution count or unit total, the scope in terms of number of kits affected has not been disclosed publicly.

What Consumers Need to Do Now

Facilities and industry users holding stock from the listed lots are advised to contact the manufacturer directly if they require additional information about the discoloration issue or how it may affect specific units. Health Canada’s guidance is to continue using the kits as intended and in line with existing facility protocols unless further instruction is issued by CHS or ICU Medical Canada.

Quick Facts

• Recall class: Type II
• Identification number: RA-82529
• Recall date: August 11, 2026
• Published/updated: August 26, 2026
• Ten affected lots across three model numbers
• Audience: Industry (healthcare facilities), not general consumers

From the Agency

Health Canada’s published summary states that CHS was notified by ICU Medical Canada of a recall of certain IV sets due to possible discoloration in the drip chamber, and that products within their expiration date carrying a drip chamber are the ones impacted. The agency notes that CHS uses these IV sets in the medical devices it manufactures, linking the two recalls together under a single notice.

Anyone seeking more detail on the affected lots or catalogue numbers is directed to contact CHS directly through its Oakville, Ontario offices for further guidance.